Brainstorm Cell diskutieren
Brainstorm Cell
WKN: A12BXW / Symbol: BCLI / Name: Brainstorm Cell / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,31 €
-2,99 %
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for BCLI provided by MarketBeat
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for BCLI provided by MarketBeat
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) had its price target raised by analysts at Maxim Group from $5.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for BCLI provided by MarketBeat
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Ratings data for BCLI provided by MarketBeat
Neueste Beiträge
StockNews_com in Concord Medical Serv. ADR diskutieren